AstraZeneca-Oxford COVID-19 Vaccine Headed for Additional Global Trial After Dosing Error
AstraZeneca Plc’s (Cambridgeshire, England) COVID-19 vaccine is reportedly headed for an additional global trial following fears of delayed approval after the announcement of interim analysis results of clinical trials which involved a dosing error. More...27 Nov 2020
First-Ever COVID-19 Severity Test to Triage Patients Quickly and Accurately
A new test offers medical criteria of COVID-19 severity and likelihood of clinical deterioration within minutes of analyzing a blood sample, allowing healthcare practitioners to decide whether COVID-19 patients should be assigned to general wards, intensive care units (ICUs) or be discharged from the hospital. More...27 Nov 2020
Global Mechanical Ventilator Market Driven by Increasing Acute Respiratory Failure in COVID-19 Patients
The global mechanical ventilator market was valued at USD 2.99 billion in 2019 and is estimated to register a CAGR of 16.5% from 2020 to 2027 to reach USD 12.54 billion by 2027, driven by the growth in geriatric population, rise in the prevalence of chronic respiratory diseases, and increase in government expenditures on healthcare. However, the high cost of mechanical ventilators and increase in incidences of ventilators-associated pneumonia are likely to restrain the market growth. Nevertheless, technological innovations, portability, and design are expected to create several opportunities for market growth in the future. More...27 Nov 2020
FDA Grants EUA to One of the First Tests That Measures Specific Levels of COVID-19 Neutralizing Antibodies
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to one of the first tests that measures specific levels of COVID-19 neutralizing antibodies. More...26 Nov 2020
Scientists Identify Human Genes That Can Protect Against COVID-19
Changes in human genes can reduce SARS-CoV-2 infection, according to a new study by scientists at the New York Genome Center (New York, NY, USA), New York University (New York, NY, USA), and the Icahn School of Medicine at Mount Sinai (New York, NY, USA). More...26 Nov 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
In-Bed Scale
IBFL500
New
Electric Cast Saw
CC4 System
In Other News
Research Sheds New Light on Genetic Risk Factors That Make Individuals More or Less Susceptible to Severe COVID-19
Demand for COVID-19 Diagnosis to Help Point of Care CT Imaging Market Reach USD 276.9 Million by 2027
Mast Group Launches New ESPLINE SARS-CoV-2 Lateral Flow Antigen Test
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test
Russia’s Sputnik V COVID-19 Vaccine Shows 95% Effectiveness in Phase 3 Clinical Trials
Cepheid Receives CE-IVD Registration for SARS-CoV-2, Flu A, Flu B and RSV Combination Test
New AI Platform Detects COVID-19 on Chest X-Rays with Accuracy and Speed
AstraZeneca-Oxford COVID-19 Vaccine Achieves Average 70% Efficacy Without Any Side Effects in Clinical Trials
Antibody Cocktails at Low Doses Could Be More Effective at Treating COVID-19, Finds Study
GE Healthcare Launches First X-Ray AI Algorithm to Help Assess Endotracheal Tube Placement for COVID-19 Patients
AI Algorithm Combines CT Images with Non-Imaging Data to Accurately Predict COVID-19 Patient Outcomes
Regeneron's REGEN-COV2 Becomes First Antibody Cocktail for COVID-19 to Receive FDA EUA
Pfizer and BioNTech Submit Emergency Use Authorization Request to FDA for COVID-19 Vaccine
Eli Lilly and Incyte’s Baricitinib Receives FDA EUA for Treatment of Hospitalized COVID-19 Patients
Gilead's Remdesivir Should Not Be Used in Hospitalized COVID-19 Patients, Says WHO
China’s Sinopharm Administers Unproven COVID-19 Vaccine to One Million People Without Any Serious Adverse Event
Ortho's CE-Marked VITROS SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals
Oxford COVID-19 Vaccine Triggers Robust Immune Response in Older Adults in Phase 2 Trial
Moderna and Pfizer COVID-19 Vaccines Could Receive EUA in a Month and Rollout in Weeks
Arthritis Drug Tocilizumab Found Effective in Treating Sickest COVID-19 Patients
First Hybridization Capture-Based NGS Assay for Characterization and Surveillance of SARS-CoV-2 Launched
Anti-COVID Nasal Spray `Ready for Use in Humans`
FDA Authorizes First COVID-19 Test for Self-Testing at Home
